Eugenia (Genie) Hong is the Clinical Trials Pharmacy Manager at The Royal Melbourne Hospital and a nationally recognised leader in investigational medicines and clinical trials pharmacy practice. Genie served as a committee member of the SHPA Specialty Practice in Investigational Drugs since 2006 and continued to be a member of the Adpha Clinical Trials Leadership committee. Genie has been involved in the development of the Standard of Practice for Pharmacy Investigational Drugs Services in Australia and has facilitated and presented at numerous clinical trials seminars and international conferences. Genie has a longstanding professional interest in GMO medicines in clinical research. She developed the Standard Operating Procedures for investigational GMO medicines at The Royal Melbourne Hospital and coordinated national training programs on GMO medicines for pharmacists through Adpha. She has over 10 years of hands-on experience with GMO medicines in clinical trial practice and co-published a review on GMO medicines and hospital pharmacy practice in the Journal of Pharmacy Practice and Research. Genie has been appointed by the Minister as a member of the Office of Gene Technology Regulator – Gene Technology Technical Advisory Committee providing scientific and technical advice to the Gene Technology Regulator and the Gene Technology Ministers’ meetings. She is also an Affiliate Professional Member of the Australian Clinical Trials Alliance (ACTA) and a member of The Royal Melbourne Hospital Human Research Ethics Committee. Genie holds a Pharmacist Consultant FANZCAP, recognised in the specialties of clinical trials and leadership and management.